Ventral Hernia Mesh Devices Market Size & Growth Forecast 2027–2036, By Segments (End Use, Mesh Type, Indication, Procedure), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Jump to Content
Market Size and Growth Outlook
Ventral Hernia Mesh Devices Market size was valued at USD 965.19 million in 2026 and is anticipated to grow at a 9.01% CAGR from 2027 to 2036, surpassing USD 2.29 billion by 2036. The industry revenue for 2027 is calculated at USD 1.04 billion.
Get more details on this report
Request Free Sample ReportVentral Hernia Mesh Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America captured 52.43% of the market in 2026, supported by advanced surgical infrastructure, established mesh-based repair practices, and growing adoption of laparoscopic and robotic-assisted procedures.
- Expanding hospital capacity, improved surgical access, and increasing adoption of minimally invasive techniques are broadening the availability of hernia repair procedures and supporting demand for mesh-based solutions.
Segment Momentum
- Inpatient facilities hold a 52.12% market share in 2026, supported by their surgical infrastructure, multidisciplinary teams, specialized equipment, and capacity to manage complex hernia procedures requiring postoperative monitoring.
- Outpatient facilities are growing fastest in 2026 as improved surgical techniques, anesthesia, patient selection, and postoperative monitoring enable more suitable hernia repairs through convenient, cost-conscious ambulatory care.
Market Expansion Drivers
- Growing prevalence of hernia and surgical procedures.
- Technological advancements in hernia mesh devices.
- Expansion of healthcare infrastructure in emerging markets.
Leading Market Participants
- Top players in the ventral hernia mesh devices market include Johnson & Johnson (USA), Medtronic (Ireland), B. Braun (Germany), BD (USA), W. L. Gore & Associates (USA), C.R. Bard (USA), Atrium Medical (USA), TELA Bio (USA), Cook Medical (USA), Cousin Biotech (France).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 965.19 million
- 2027 Estimated Market Size: USD 1.04 billion
- Projected Market Size: USD 2.29 billion by 2036
- Growth Forecast: 9.01% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: End Use (Inpatient Facilities) | Mesh Type (Non-resorbable Mesh) | Indication (Incisional Hernia) | Procedure (Open Surgery)
- Emerging Opportunity Segment: End Use (Outpatient Facilities) | Mesh Type (Non-resorbable Mesh) | Indication (Incisional Hernia) | Procedure (Robotic Surgery)
Market Growth Drivers and Industry Trends
Growing prevalence of hernia and surgical procedures
The growing prevalence of hernia conditions is contributing to demand for ventral hernia mesh devices as surgical repair remains an important treatment approach for patients requiring intervention. Increasing diagnosis of hernia cases and greater access to surgical care are supporting the need for effective repair materials that can reinforce weakened abdominal tissue. Moreover, improvements in surgical techniques and growing awareness of treatment options are encouraging the use of mesh-based repair approaches in appropriate clinical settings.
Technological advancements in hernia mesh devices
Technological advancements in hernia mesh devices are supporting market growth by improving material properties, flexibility, biocompatibility, and suitability for different surgical requirements. Manufacturers are increasingly focusing on mesh designs that can provide effective tissue support while addressing concerns related to healing, handling, and postoperative outcomes. Furthermore, developments in surgical techniques and device configurations are expanding the range of options available to healthcare professionals, supporting continued adoption of advanced hernia repair technologies.
Expansion of healthcare infrastructure in emerging markets
The expansion of healthcare infrastructure in emerging markets is creating opportunities for ventral hernia mesh devices as hospitals, surgical centers, and specialized medical facilities improve access to surgical care. Increasing healthcare investment and the development of modern treatment facilities are enabling more patients to receive diagnosis and appropriate surgical intervention. Additionally, growing awareness of advanced surgical procedures among healthcare professionals and patients is supporting the adoption of modern hernia repair technologies across developing healthcare systems.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Growing prevalence of hernia and surgical procedures | 3% | Short term (≤ 2 yrs) | North America; Europe | High | Fast |
| Technological advancements in hernia mesh devices | 3% | Medium term (2–5 yrs) | Europe; Asia Pacific | Medium | Moderate |
| Expansion of healthcare infrastructure in emerging markets | 2.9% | Long term (5+ yrs) | Asia Pacific; Latin America | Medium | Moderate |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
North America accounted for the largest share of the ventral hernia mesh devices market, with a 52.43% share in 2026, supported by advanced surgical infrastructure, high adoption of mesh-based hernia repair, and strong emphasis on minimally invasive procedures. The region benefits from widespread access to specialized surgical care and established clinical practices for managing ventral hernias. Growing preference for laparoscopic and robotic-assisted repair techniques is supporting demand for mesh devices designed to facilitate effective abdominal wall reconstruction while minimizing surgical trauma. In addition, continued improvements in mesh materials, fixation approaches, and device designs are enabling surgeons to select products according to patient anatomy and procedural requirements, supporting sustained market development.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is expected to experience the fastest growth in the ventral hernia mesh devices market, propelled by expanding healthcare infrastructure, increasing access to surgical services, and growing adoption of minimally invasive techniques. Improvements in hospital capacity and specialist surgical expertise are increasing the availability of hernia repair procedures across emerging healthcare markets. Greater awareness of treatment options and improving access to diagnosis are also encouraging patients to seek surgical management, creating additional demand for mesh-based repair solutions. Furthermore, the adoption of laparoscopic and advanced surgical technologies is expanding as healthcare providers modernize operating facilities and strengthen surgical capabilities, supporting broader use of ventral hernia mesh devices across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation HubiScaleNascentDeveloping Advanced | |||||
| Cost-Sensitive RegioniScaleLowMedium High | |||||
| Regulatory EnvironmentiScaleRestrictiveNeutral Supportive | |||||
| Demand DriversiScaleWeakModerate Strong | |||||
| Development StageiScaleEmergingDeveloping Developed | |||||
| Adoption RateiScaleLowMedium High | |||||
| New Entrants / StartupsiScaleSparseModerate Dense | |||||
| Macro IndicatorsiScaleWeakStable Strong |
Key Country Insights
United States 🇺🇸
Advanced Hernia RepairThe U.S. ventral hernia mesh devices market prioritizes durable repair, surgical efficiency, and differentiated mesh technologies across open, laparoscopic, and robotic procedures. Manufacturers are focusing on improved material design, fixation approaches, and clinical performance while providers remain attentive to complications and long-term patient outcomes.
Germany 🇩🇪
Evidence-Based Surgical CareGermany’s ventral hernia mesh devices market is driven by structured surgical practice and emphasis on clinical evidence. Hospitals and surgeons prioritize mesh products with established safety profiles, appropriate anatomical performance, and compatibility with minimally invasive repair techniques.
Japan 🇯🇵
Minimally Invasive RepairJapan’s ventral hernia mesh devices market is increasingly aligned with minimally invasive surgical approaches and careful device selection. Manufacturers are prioritizing lightweight or anatomically adaptable mesh designs, while hospitals emphasize reliable handling, patient safety, and integration with established surgical protocols.
South Korea 🇰🇷
Surgical Technology IntegrationSouth Korea’s ventral hernia mesh devices market is supported by adoption of advanced surgical techniques, including laparoscopic and robotic repair. Suppliers are concentrating on mesh designs that facilitate minimally invasive procedures, dependable fixation, and improved postoperative management.
France 🇫🇷
Hospital-Based Hernia CareFrance’s ventral hernia mesh devices market is shaped by hospital-based surgical care and increasing attention to minimally invasive repair. Market priorities include dependable mesh performance, appropriate patient selection, and products that support efficient procedures while addressing postoperative complication risks.
Italy 🇮🇹
Procedure-Focused Device SelectionItaly’s ventral hernia mesh devices market centers on hospital surgical demand and evolving minimally invasive techniques. Healthcare providers and suppliers are focused on cost-conscious procurement alongside mesh quality, ease of implantation, and suitability for different ventral hernia repair procedures.
Ventral Hernia Mesh Devices Market Share (%), by End Use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd Use Segment Analysis: Inpatient Facilities (Largest Segment) vs Outpatient Facilities (Fastest-Growing Segment)
Inpatient facilities account for a 52.12% share of the ventral hernia mesh devices market in 2026, reflecting the continued role of hospitals and other inpatient settings in managing complex hernia cases and procedures that require surgical resources and post-operative monitoring. These facilities typically provide access to multidisciplinary clinical teams, operating infrastructure, and perioperative care, supporting the use of ventral hernia mesh devices in a range of repair procedures. Patient complexity and the need for coordinated surgical management reinforce demand in inpatient environments. Established hospital-based surgical pathways and access to specialized equipment further contribute to the segment’s leading share position in 2026.
The outpatient facilities segment is expected to grow fastest in 2026 as advances in surgical techniques, anesthesia, and perioperative care support the treatment of suitable hernia cases in ambulatory settings, increasing its relative market share. Outpatient care can offer greater convenience and may reduce the need for extended facility stays, aligning with healthcare providers’ interest in efficient care delivery. Improvements in patient selection, minimally invasive approaches, and post-procedure monitoring are helping expand the range of procedures that can be performed outside traditional inpatient settings. Continued emphasis on cost-conscious care and recovery pathways is further supporting adoption of ventral hernia mesh devices in outpatient facilities during 2026.
Mesh Type Segment Analysis: Non-resorbable Mesh (Largest & Fastest-Growing Segment)
The non-resorbable mesh segment holds a 50.03% market share in the ventral hernia mesh devices market for 2026 and is also expected to grow fastest, supported by its established use in hernia repair procedures requiring durable reinforcement of the abdominal wall. These meshes are designed to remain in place and provide ongoing structural support as tissue heals, making them a widely used option across different surgical approaches and patient needs. Familiarity among surgeons, established clinical experience, and the availability of varied mesh designs contribute to continued adoption. Ongoing product development focused on material properties, handling, and compatibility with surgical techniques is also supporting the segment’s relevance in ventral hernia mesh devices during 2026.
Indication Segment Analysis: Incisional Hernia (Largest & Fastest-Growing Segment)
In 2026, the incisional hernia indication accounts for a 46% share of the ventral hernia mesh devices market and is expected to remain the fastest-growing indication, reflecting the need to repair abdominal wall weaknesses that develop at the site of previous surgical incisions. Mesh-based repair is widely used to reinforce the affected area and address the risk of recurrence, making ventral hernia mesh devices an important part of treatment planning. Demand is supported by the volume of abdominal surgeries that can lead to incisional hernias, alongside greater clinical attention to effective repair and long-term outcomes. Advances in surgical methods and mesh design are also helping clinicians tailor treatment to hernia characteristics and patient requirements, supporting continued usage and share expansion in this indication throughout 2026.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End Use | Inpatient Facilities, Outpatient Facilities | Inpatient Facilities | Outpatient Facilities |
| Mesh Type | Resorbable Mesh, Partially Absorbable Mesh, Non-resorbable Mesh | Non-resorbable Mesh | Non-resorbable Mesh |
| Indication | Umbilical Hernia, Epigastric Hernia, Incisional Hernia, Others | Incisional Hernia | Incisional Hernia |
| Procedure | Open Surgery, Laparoscopic Surgery, Robotic Surgery, Others | Open Surgery | Robotic Surgery |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Analyst Perspective:
Modern competitive advantages in the ventral hernia mesh market are driven by advanced biomaterial engineering and seamless integration into minimally invasive surgical workflows. Device manufacturers are increasingly challenged to balance temporary mechanical support with long-term tissue repair, driving innovation in resorbable biopolymers, composite materials, and durable anti-adhesive barriers that protect visceral organs. Simultaneously, mesh adoption relies heavily on handling characteristics that accommodate robotic and laparoscopic delivery without sacrificing repair integrity. Ultimately, market leadership belongs to manufacturers that substantiate their material innovations with robust clinical evidence demonstrating predictable tissue ingrowth, low complication rates, and sustained reductions in hernia recurrence.
Key companies in the ventral hernia mesh devices market:
- Johnson & Johnson (USA)
- Medtronic (Ireland)
- B. Braun (Germany)
- BD (USA)
- W. L. Gore & Associates (USA)
- C.R. Bard (USA)
- Atrium Medical (USA)
- TELA Bio (USA)
- Cook Medical (USA)
- Cousin Biotech (France)
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Johnson & Johnson (USA) | |||||||
| Medtronic (Ireland) | |||||||
| B. Braun (Germany) | |||||||
| BD (USA) | |||||||
| W. L. Gore & Associates (USA) | |||||||
| C.R. Bard (USA) | |||||||
| Atrium Medical (USA) | |||||||
| TELA Bio (USA) | |||||||
| Cook Medical (USA) | |||||||
| Cousin Biotech (France) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| BD (Becton, Dickinson and Company) | April 2025 | BD secured FDA 510(k) clearance and launched the Phasix ST Umbilical Hernia Patch, a fully absorbable mesh designed specifically for umbilical hernia repair. This commercial introduction expands the company's specialized surgical product portfolio and addresses clinical demand for absorbable fixation alternatives. |
| RTI Surgical, Inc. | February 2024 | RTI Surgical acquired Cook Group Incorporated to expand its surgical and regenerative medicine portfolio. This strategic transaction broadens the company's assortment of biologic and synthetic offerings, strengthening its commercial position and capacity to deliver advanced hernia repair and wound management solutions. |
| Advanced Medical Solutions Limited | June 2023 | Advanced Medical Solutions Limited received FDA approval for its LiquiFix FIX8 and Precision Hernia Mesh Fixation Devices. These liquid adhesive systems secure mesh during open and laparoscopic procedures, offering increased fixation points and minimizing post-operative pain compared to traditional mechanical tacks. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Ventral Hernia Mesh Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Fixation Method | Sutures, Tacks & Fixation Devices, Fibrin/Adhesive Fixation, Self-Gripping Mesh |
| Mesh Placement | Onlay, Sublay/Retromuscular, Preperitoneal, Intraperitoneal, Inlay |
| Product Format | Flat Mesh, Pre-Shaped Mesh, Composite Mesh, Three-Dimensional Mesh |
Ventral Hernia Mesh Devices Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Hernia Repair Procedure Pathway Analysis |
|
| Mesh Adoption Barriers & Physician Preferences |
|
| Postoperative Outcomes & Revision Patterns |
|
Need a different cut of the data?
Request Custom ResearchFrequently Asked Questions
How big is the ventral hernia mesh devices market?
What is the forecasted size of the ventral hernia mesh devices industry?
How are advances in hernia mesh technology influencing clinical adoption?
How is healthcare infrastructure expansion in emerging markets creating opportunities for hernia mesh devices?
Why do inpatient facilities dominate the ventral hernia mesh devices market?
What is driving growth in outpatient facilities for ventral hernia mesh devices?
Why does North America dominate the ventral hernia mesh devices market?
How is Asia Pacific creating new growth opportunities for ventral hernia mesh devices?
Who holds a significant market share in the ventral hernia mesh devices landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.
Delivery
Published
Available
Support
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook